Do Analysts Expect Ampio Pharmaceuticals Inc (AMPE) Stock to Rise After It Is Lower By -51.35% in a Month?

InvestorsObserver is giving Ampio Pharmaceuticals Inc (AMPE) an Analyst Rating Rank of 72, meaning AMPE is ranked higher by analysts than 72% of stocks. The average price target for AMPE is $2.5 and analyst’s rate the stock as a Strong Buy.

Wall Street analysts are rating AMPE a Strong Buy today. Find out what this means to you and get the rest of the rankings on AMPE!

See Full AMPE Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Ampio Pharmaceuticals Inc Stock Today?

Ampio Pharmaceuticals Inc (AMPE) stock is lower by -9.58% while the S&P 500 is up 1.04% as of 10:33 AM on Tuesday, May 17. AMPE has fallen -$0.02 from the previous closing price of $0.20 on volume of 2,312,001 shares. Over the past year the S&P 500 is lower by -2.73% while AMPE has fallen -90.22%. AMPE lost -$0.09 per share the over the last 12 months. Click Here to get the full Stock Report for Ampio Pharmaceuticals Inc stock.